Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
US Stock MarketDetailed Quotes
TPST Tempest Therapeutics
- 6.990
- +0.140+2.04%
Close May 2 16:00 ET
- 7.050
- +0.060+0.86%
Post 20:01 ET
24.61MMarket Cap-0.36P/E (TTM)
7.230High6.630Low57.60KVolume6.960Open6.850Pre Close398.76KTurnover1.78%Turnover RatioLossP/E (Static)3.52MShares49.27052wk High1.29P/B22.67MFloat Cap5.34352wk Low--Dividend TTM3.24MShs Float3381.300Historical High--Div YieldTTM8.76%Amplitude2.210Historical Low6.923Avg Price1Lot Size
About Tempest Therapeutics Company
Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients. Tempest Therapeutics was founded in 2011 and is headquartered in Brisbane, CA.
Company Profile
SymbolTPST
Company NameTempest Therapeutics
Listing DateApr 30, 2013
Founded2011
CEOMr. Stephen R. Brady
MarketNASDAQ
Employees25
Fiscal Year Ends12-31
Address2000 Sierra Point Parkway,Suite 400
CityBrisbane
ProvinceCalifornia
CountryUnited States of America
Zip Code94005
Phone1-415-798-8589
Websitehttp://www.tempesttx.com
Company Executives
- Name
- Position
- Salary
- Stephen R. Brady
- Director, Chief Executive Officer and President
- --
- Dr. Samuel Whiting, M.D.,PhD
- Executive Vice President and Chief Medical Officer
- --
- Nicholas Maestas
- Chief Financial Officer and Head of Corporate Strategy
- --
- Justin Trojanowski
- Corporate Controller, Treasurer and Principal Accounting Officer
- --
- Michael G. Raab
- Chairman of the Board
- --
- Christine A. Pellizzari
- Independent Director
- --
- Dr. Ronit Simantov, M.D.
- Independent Director
- --
- Dr. Geoffrey M. Nichol, Ch.B.,M.B.,M.B.A.
- Independent Director
- --
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. Do you think Buffett was scooping up stocks during the recent dip? 2. In the face of market changes, do you prefer to stick
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now